Eris Lifesciences Limited has informed the Exchange regarding Allotment of 19624 Shares.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has allotted 19,624 equity shares on March 12, 2026, pursuant to the exercise of stock options under its ESOP-2021 Scheme. The shares were granted across three years — 3,839 shares (FY2022 grant) at Rs. 557.24 each, 7,776 shares (FY2023 grant) at Rs. 510.32 each, and 8,009 shares (FY2024 grant) at Rs. 728.16 each. As a result, the company's paid-up equity share capital has risen from Rs. 13.85 crore (13,85,23,263 shares) to Rs. 13.85 crore (13,85,42,887 shares) of Re. 1 each. The dilution impact is marginal, representing roughly 0.14% of the existing share base.
This is a routine ESOP allotment and unlikely to have any material impact on the stock price. The slight increase in share count is negligible relative to total shares outstanding, and the shares were issued at pre-set exercise prices, not at market discount.